News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mersana Therapeutics, Inc. Earns Second Milestone Payment In Fleximer-ADC Collaboration With Endo Pharmaceuticals (ENDP)


1/9/2014 10:12:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana Therapeutics, Inc. announced today that it has achieved its second preclinical milestone in its collaboration with Endo Pharmaceuticals (Nasdaq: ENDP). In 2012, Mersana and Endo entered into a multi-target, oncology focused partnership to develop next-generation Fleximer® antibody-drug conjugates (ADCs).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES